scout
|Videos|February 2, 2017

The Future of Immune Checkpoint Inhibition in Gastric and Esophageal Cancers

Geoffrey Y. Ku, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the future of immune checkpoint inhibition in gastric and esophageal cancers.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME